
SK bioscience Begins Exporting SKYCellflu Influenza Vaccine to Southern Hemisphere Markets
SK bioscience announced that it has begun shipping its self-developed influenza vaccine, SKYCellflu, to Southern Hemisphere markets, including regions in Southeast Asia and Latin America. The shipments from its L HOUSE vaccine manufacturing facility will …